The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study

MLA

Kaiser, Jeenan, et al. “The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.” Bladder Cancer, vol. 4, no. 2, Apr. 2018, pp. 185–94. EBSCOhost, https://doi.org/10.3233/BLC-170133.

APA

Kaiser, J., Li, H., North, S. A., Leibowitz-Amit, R., Seah, J.-A., Morshed, N., Chau, C., Lee-Ying, R., Heng, D. Y. C., Sridhar, S., Crabb, S. J., & Alimohamed, N. S. (2018). The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study. Bladder Cancer, 4(2), 185–194. https://doi.org/10.3233/BLC-170133

Chicago

Kaiser, Jeenan, Haocheng Li, Scott A. North, Raya Leibowitz-Amit, Jo-An Seah, Nisha Morshed, Caroline Chau, et al. 2018. “The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.” Bladder Cancer 4 (2): 185–94. doi:10.3233/BLC-170133.